Ë®ðåÐÔ¿ÚÑײ¡¶¾£¨Vesicular stomatitis virus£¬VSV£©ÔØbjlƽ̨¹ÙÍøÔÚÑо¿²¡¶¾¿ÅÁ£ÈëÇÖËÞÖ÷bjlƽ̨¡¢±æÈϽ鵼²¡¶¾¸ÐȾbjlƽ̨µÄbjlƽ̨±íÃæÊÜbjlƽ̨¹ÙÍø¡¢É¸Ñ¡²¡¶¾ÒÖÖÆÒ©ÎïÒÔ¼°ÒßÃ翪·¢·½ÃæÓÐ׏㷺µÄÓ¦Óá£VSV²¡¶¾ÔØbjlƽ̨¹ÙÍø¿ÉÒÔ¸ßЧµØÀûÓÃÒìÔ´²¡¶¾µÄ°üĤµ°°×½øÐмÙÐÍ»¯£¨Presudotypted£©£¬±ÈÈçÄÇЩÐèÒªÔÚ¸ßÉúÎﰲȫµÈ¼¶ÊµÑéÊÒ²Ù×÷µÄ²¡¶¾µÄ°üĤµ°°×¡£ÖØ×éVSVÔÚËÞÖ÷bjlƽ̨Öв»ÄܽøÐг¬¹ýÒ»Âֵĸ´ÖÆ£¬Òò´Ë¿ÉÒÔÔÚÉúÎﰲȫ2¼¶£¨BSL2£©ÊµÑéÊbjlƽ̨¹ÙÍøøÐÐÏà¹Ø²Ù×÷¡£ÕâÐ©ÌØµã´ÙʹVSV²¡¶¾ÔØbjlƽ̨¹ÙÍø³ÉΪÔÚÎÞÐè¸ß¶È¸ôÀëÏÂÑо¿¸ß·çÏÕ²¡¶¾ÇÖÈëbjlƽ̨»úÖÆµÄÀíÏëÑ¡Ôñ¡£
Ò°ÉúÐÍVSVÊôÓÚµ¯×´²¡¶¾¿Æ£¨Rhabdoviridae£©£¬ÓµÓÐÒ»Ìõµ¥Á´¸ºÒåRNA»ùÒò×飬²¢ÇÒÆä¸´ÖÆÒÀÀµ²¡¶¾µÄRNAÒÀÀµµÄRNA¾ÛºÏø£¨RNA-dependent RNA polymerase£¬RdRp£©¡£VSVµÄµ¥Á´RNA»ùÒò×é±àÂëÒÔÏÂÎåÖÖµ°°××é·Ö£ººËµ°°×£¨N£©¡¢Á×Ëữµ°°×£¨P£©¡¢»ùÖʵ°°×£¨M£©¡¢Ìǵ°°×£¨G£©ºÍ²¡¶¾RdRpµÄ´óÑÇ»ù£¨L£©¡£VSV²¡¶¾¿ÅÁ£ÖУ¬ÆäRNA»ùÒò×éÓëNºËµ°°××é³ÉºËÌǺËËáµ°°×£¨Ribonucleoprotein£¬RNP£©¡£PºÍLµ°°×Ôò×é³ÉRdRp£¬²¢½áºÏÓÚRNP¡£VSV¸ÐȾ°Ðbjlƽ̨ʱ£¬ÆäGÌǵ°°×ÓÕµ¼bjlƽ̨·¢ÉúÄÚÍÌ×÷Ó㬰ïÖú²¡¶¾ÇÖÈëbjlƽ̨¡£GÌǵ°°×¿ÉÒԽ鵼²¡¶¾°üĤÓëbjlƽ̨ĤÈںϣ¬´ÙʹRNPºÍRdRpÒ»ÆðÊͷŵ½bjlƽ̨ÖÊÖС£²¡¶¾×é·Ö½øÈëbjlƽ̨ºó£¬RdRpÒÔRNPÖеĸºÒåRNA»ùÒò×éΪģ°åÁ¢¼´Æô¶¯Ò»¼¶×ªÂ¼£¬¶ø×÷Ϊת¼²úÎïµÄÕýÒåRNAÁ´±»½øÒ»²½·Ò룬ÓÃÓÚÉú²ú½éµ¼²¡¶¾»ùÒò×鏴֯¡¢¶þ¼¶×ªÂ¼¡¢²¡¶¾×é×°ºÍ³öÑ¿µÈ²¡¶¾µÈ¹¦ÄܵĺóÆÚµ°°×¡£
?
¹ØÓÚ¸ÃÔØbjlƽ̨¹ÙÍøÏµÍ³µÄ¸ü¶àÐÅÏ¢£¬Çë²Î¿¼ÒÔÏÂÎÄÏס£
| ²Î¿¼ÎÄÏ× | Ö÷Ìâ |
|---|---|
| Hum Vaccin Immunothera. 15:2269 (2019) | Recombinant vesicular stomatitis vector vaccines |
| Vaccine. 34:6597 (2016) | Risk/benefit assessment of live viral vaccines based on VSV |
| Front Microbiol. 2:272 (2012) | Development and applications of VSV vectors |
| J Virol Methods. 169:365 (2010) | Generation of VSV pseudotypes using recombinant VSV-delta G |
| J Gen Virol. 86:2269 (2005) | Generation of VSV pseudotyped with coronavirus spike protein |
| Virology. 286:263 (2001) | Characterization of VSV pseudotyped with HCV envelop proteins |
ɨһɨ£¬¹Ø×¢ÎÒÃÇ×îÐÂÏûÏ¢ ¹¤×÷ʱ¼ä£ºÖÜÒ»ÖÁÖÜÎå 9:00-18:00
ÁªÏµÈË£ºÀµÅ®Ê¿
ÊÖ»ú£º13670105633
Óʼþ£ºlaijiaqi@sz-cell.com
µØÖ·£ºÉîÛÚÊÐÆºÉ½Çø¿Óè÷½ÖµÀ½ðɳÉçÇøÈÙÌï·1ºÅº£ÆÕÈðÉúÎïbjlƽ̨¹ÙÍøÒ©Éú̬԰
